VOTING AGREEMENTVoting Agreement • July 10th, 1998 • Gene Logic Inc • Services-commercial physical & biological research • Maryland
1 EXHIBIT 10.46 LOAN AGREEMENTLoan Agreement • July 29th, 1998 • Gene Logic Inc • Services-commercial physical & biological research • Maryland
Exhibit 10.99 Exhibit 10.99 - Asset Purchase Agreement ASSET PURCHASE AGREEMENT by and between GENE LOGIC INC.Asset Purchase Agreement • October 18th, 2007 • Gene Logic Inc • In vitro & in vivo diagnostic substances • Maryland
DRAFT DATED 10/7/97 3,000,000 Shares (1) GENE LOGIC INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 7th, 1997 • Gene Logic Inc • California
RECITALSLease • March 29th, 2001 • Gene Logic Inc • Services-commercial physical & biological research
AGREEMENTAgreement • May 14th, 1999 • Gene Logic Inc • Services-commercial physical & biological research • California
EXHIBIT 10.66 SETTLEMENT AGREEMENT 1. INTRODUCTION OF THE PARTIES This agreement (the "Agreement") is made as of June 16, 2000 (the "Effective Date") by and between: 1.1. Gene Logic Inc., a Delaware corporation, having its registered office at 708...Settlement Agreement • August 14th, 2000 • Gene Logic Inc • Services-commercial physical & biological research
BETWEENLease Agreement • August 14th, 2003 • Gene Logic Inc • In vitro & in vivo diagnostic substances • Maryland
EXHIBIT 10.79 LEASE AGREEMENT THIS LEASE AGREEMENT, made this 20(th) day of November, 1999, by and between RICKMAN FIRSTFIELD ASSOCIATES ("LANDLORD") and THERIMMUNE RESEARCH CORPORATION ("TENANT'). W I T N E S S E T H: 1. DEMISE OF PREMISES Landlord...Lease Agreement • August 14th, 2003 • Gene Logic Inc • In vitro & in vivo diagnostic substances
Exhibit 10.97 EXECUTIVE EMPLOYMENT AGREEMENT ------------------------------ THIS EMPLOYMENT AGREEMENT (the "Agreement") is entered into as of the 21st day of March, 2007 by and between Gene Logic Inc., a Delaware corporation (the "Company"), and...Executive Employment Agreement • July 12th, 2007 • Gene Logic Inc • In vitro & in vivo diagnostic substances • Maryland
LEASE -----Lease • November 14th, 2000 • Gene Logic Inc • Services-commercial physical & biological research • Maryland
Exhibit 10.23 THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT...Warrant Agreement • October 21st, 1997 • Gene Logic Inc • Services-commercial physical & biological research • Delaware
RECITALS:Employment Agreement • July 29th, 1998 • Gene Logic Inc • Services-commercial physical & biological research
Exhibit 10.7 GENE LOGIC INC. 1997 NON-EMPLOYEE DIRECTORS' STOCK OPTION PLANNonstatutory Stock Option Agreement • October 7th, 1997 • Gene Logic Inc
BETWEENCollaboration Agreement • July 29th, 1998 • Gene Logic Inc • Services-commercial physical & biological research • Maryland
1 EXHIBIT 1.1 Gene Logic Inc. 3,500,000 Shares of Common Stock* (par value $.01 per share) UNDERWRITING AGREEMENTUnderwriting Agreement • January 25th, 2000 • Gene Logic Inc • Services-commercial physical & biological research • New York
RECITALSAffiliate Agreement • July 29th, 1998 • Gene Logic Inc • Services-commercial physical & biological research • Maryland
VOTING AGREEMENTVoting Agreement • July 10th, 1998 • Gene Logic Inc • Services-commercial physical & biological research • Maryland
Exhibit 10.62 NEURALSTEM BIOPHARMACEUTICALS, LTD. SERIES A PREFERRED STOCK PURCHASE AGREEMENT APRIL 20, 2000 2Series a Preferred Stock Purchase Agreement • May 15th, 2000 • Gene Logic Inc • Services-commercial physical & biological research • Maryland
RECITALSEmployment Agreement • October 2nd, 2008 • Gene Logic Inc • In vitro & in vivo diagnostic substances
July 28, 1998Agreement and Plan of Merger and Reorganization • July 29th, 1998 • Gene Logic Inc • Services-commercial physical & biological research
Exhibit 10.31License Agreement • October 7th, 1997 • Gene Logic Inc • Delaware
Exhibit 10.18 THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED,...Warrant Agreement • October 7th, 1997 • Gene Logic Inc • Delaware
trading days prior to the date of exercise, (b) if the Common Stock is then regularly traded over-the-counter, the average of the sale prices or secondarily the closing bid of the Common Stock over the 20 trading day period ending three (3) trading days prior to the date of exercise, or (c) if there is no active public market for the Common Stock, the fair market value thereof shall be determined in good faith by the Company's Board of Directors. In the event the holder of this Warrant exercises this Warrant contingent upon the closing of a public offering, the "fair market value" of a share of Common Stock on the date of exercise shall be equal to the initial price to the public specified in the final prospectus with respect to such public offering. The following diagram illustrates how many shares would then be issued upon exercise pursuant to this Section 1.5: Let FMV = Fair market value per share of Common Stock at date of exercise. PSP = Per share Warrant Price at date of exercise
RECITALS:Employment Agreement • May 15th, 2000 • Gene Logic Inc • Services-commercial physical & biological research
Exhibit 10.98 ADVISORY SERVICES AGREEMENT THIS Agreement ("Agreement"), effective as of September 1, 2007 is entered into by and between Gene Logic Inc. ("GLGC"), with a place of business at 50 West Watkins Mill Road, Gaithersburg, Maryland 20878, and...Advisory Services Agreement • October 18th, 2007 • Gene Logic Inc • In vitro & in vivo diagnostic substances • Maryland
RECITALS:Employment Agreement • March 30th, 2000 • Gene Logic Inc • Services-commercial physical & biological research
BETWEENProduct Purchase Agreement • May 15th, 2000 • Gene Logic Inc • Services-commercial physical & biological research • Delaware
RECITALSIndemnification Agreement • October 7th, 1997 • Gene Logic Inc • Delaware
RECITALSEmployment Agreement • August 13th, 1999 • Gene Logic Inc • Services-commercial physical & biological research
Exhibit 10.9 GENE LOGIC INC.Stock Restriction Agreement • October 7th, 1997 • Gene Logic Inc • Delaware
Exhibit 10.88 EXECUTIVE EMPLOYMENT AGREEMENT ------------------------------ THIS EMPLOYMENT AGREEMENT (the "Agreement") is entered into as of the 6th day of March, 2005 by and between Gene Logic Inc., a Delaware corporation (the "Company"), and V. W....Executive Employment Agreement • March 10th, 2005 • Gene Logic Inc • In vitro & in vivo diagnostic substances • Maryland
AND PLAN OF MERGER AND REORGANIZATION AMONG GENE LOGIC INC., GENE LOGIC ACQUISITION CORP. AND ONCORMED, INC. JULY 6, 1998 TABLE OF CONTENTSMerger Agreement • July 10th, 1998 • Gene Logic Inc • Services-commercial physical & biological research • Maryland
1 EXHIBIT 10.69 AMENDMENT TO EMPLOYMENT AGREEMENT THIS AMENDMENT TO EMPLOYMENT AGREEMENT (this "Amendment") is made and entered into as of July 9, 1997, by and between GENE LOGIC INC., a Delaware Corporation (the "Company"), and ERIC M. EASTMAN...Employment Agreement • March 29th, 2001 • Gene Logic Inc • Services-commercial physical & biological research
EMPLOYMENT AGREEMENTEmployment Agreement • October 7th, 1997 • Gene Logic Inc
LEASE RREEF AMERICA REIT II CORP. PPP, Landlord, and ORE PHARMACEUTICALS INC., Tenant Riverfront Office Park Cambridge, MassachusettsLease • August 14th, 2009 • Ore Pharmaceuticals Inc. • In vitro & in vivo diagnostic substances
By this Lease Landlord leases to Tenant and Tenant leases from Landlord the Premises in the Building as set forth and described on the Reference Pages. The Premises are depicted on the floor plan attached hereto as Exhibit A, and the Building is depicted on the site plan attached hereto as Exhibit A-1. The Building is located on the Lot legally described on Exhibit A-2. The Reference Pages, including all terms defined thereon, are incorporated as part of this Lease.
